Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population diversity of Plasmodium falciparum during ACT adoption in Nigerian children
PACTR202106708800075Not yet recruiting
- Sponsor
- Kazeem Akano
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dihydroartemisinin + piperaquine and artemether + lumefantrine in malaria (2 arms), sponsored by Kazeem Akano. Primary endpoints: Asexual parasite positivity, Parasite clearance time and 5 more. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
dihydroartemisinin + piperaquineartemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202106708800075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202106708800075.